AMENDMENT to FIRMINVEST AG COMMITMENT LETTERCommitment Letter Amendment • August 17th, 2007 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations
This Amendment (the “Amendment”), effective as of June 30, 2007 (the “Effective Date”), is attached to and made part of the commitment letter dated May 20, 2007 and accepted on May 21, 2007 (the “Commitment Letter”) between FirmInvest AG (“FirmInvest”) and CardioVascular BioTherapeutics, Inc., a Nevada corporation (“Cardio”) regarding a foreign private placement being conducted under Regulation S of the Securities Act of 1993 to sell 15,000,000 shares of common stock of CardioVascular BioTherapeutics, Inc. at US$1.00 per shares (the “Reg S Offering”).
